Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 95

Results For "TD"

1272 News Found

Aurobindo Pharma Q4 PAT drops 28% to Rs 576 Cr
News | June 06, 2022

Aurobindo Pharma Q4 PAT drops 28% to Rs 576 Cr

Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore


Thyrocare opens regional processing lab in Ahmedabad
News | June 06, 2022

Thyrocare opens regional processing lab in Ahmedabad

New Regional Processing Lab will serve Ahmedabad and the state of Gujarat


Proexp Pharma collaborates with Carbanio
News | June 02, 2022

Proexp Pharma collaborates with Carbanio

As per partnership, Carbanio will arrange raw materials and other custom chemicals for Proexp Pharma Pvt. Ltd. through an uninterrupted digital process of the company


ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops
Drug Approval | June 01, 2022

ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops

Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children


Thyrocare unveils new brand identity
News | June 01, 2022

Thyrocare unveils new brand identity

New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services


Glenmark Pharma reports revenue growth of 5.6% YoY in Q4
News | May 30, 2022

Glenmark Pharma reports revenue growth of 5.6% YoY in Q4

Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022


A.Menarini expands its dermatology portfolio with the launch of Solar D
Healthcare | May 27, 2022

A.Menarini expands its dermatology portfolio with the launch of Solar D

The groundbreaking SPF technology is specifically designed and formulated to prevent sunburn or sun damage while allowing the passage of sufficient UVB light that our bodies use to naturally produce vitamin D


Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities
News | May 26, 2022

Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities

ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E


Driving sustainable, enterprise-wide performance acceleration
Opinion | May 19, 2022

Driving sustainable, enterprise-wide performance acceleration

Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time


Sahajanand Medical Technologies win award for Supraflex Cruz
Medical Device | May 17, 2022

Sahajanand Medical Technologies win award for Supraflex Cruz

Union Minister of State for Science and Technology, Dr Jitendra Singh gave the award for the successful commercialization of indigenous technology on National Technology Day 2022